Atea Pharmaceuticals, Inc. (AVIR) SEC Filings — 2024
19 SEC filings for Atea Pharmaceuticals, Inc. (AVIR) in 2024.
Filings
- Atea Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Atea Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Atea Pharmaceuticals Files 8-K on Financials — 8-K · Nov 7, 2024
- Atea Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Atea Pharmaceuticals Files 8-K on Financials — 8-K · Aug 7, 2024
- Atea Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
- Atea Pharmaceuticals Holds Annual Meeting, Elects Directors — 8-K · Jun 21, 2024
- Atea Pharmaceuticals Files Proxy Supplement — DEFA14A · Jun 4, 2024
- Atea Pharmaceuticals Files 8-K on Financials — 8-K · May 14, 2024
- Atea Pharmaceuticals Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Atea Pharmaceuticals, Inc. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 26, 2024
- Atea Pharma Files 8-K on Financial Condition and Operations — 8-K · Feb 28, 2024
- Atea Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
- Atea Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Atea Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Atea Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- FMR LLC & Abigail Johnson Trim Atea Pharma Stake to 6.412% — SC 13G/A · Feb 9, 2024
- BML Investment Partners Amends Atea Pharma Stake, Forms Group — SC 13G/A · Feb 7, 2024
- BlackRock Updates Passive Stake in Atea Pharmaceuticals — SC 13G/A · Jan 24, 2024